RETRACTED: Fahmy et al. Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation. Pharmaceutics 2020, 12 , 485.
The article titled "Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation" has been retracted by the journal Pharmaceutics. Concerns were raised about the overlap of images in the article, and an investigation confirmed that Figure 5 overlapped with prior and later publications. The authors were unable to provide a satisfactory explanation for the overlap or meet the required quality standards for the raw images. As a result, the Editorial Board and Editor-in-Chief decided to retract the paper. The authors did not agree with this retraction.